Prospective identification and causality evaluation of suspected adverse drug reactions in neonates-Reference-Cited by-同舟云学术

Prospective identification and causality evaluation of suspected adverse drug reactions in neonates

Published:2020-09-07 Issue:3 Volume:87 Page:1541-1546
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Roberts Eve K.¹^ORCID,Hawcutt Daniel B.¹²^ORCID,Turner Mark A.¹³^ORCID

Affiliation:

1. Department of Women's and Children's Health, Institute of Lifecourse and Medical Science University of Liverpool, Liverpool Health Partners Liverpool UK

2. NIHR Alder Hey Clinical Research Facility Alder Hey Children's Hospital Liverpool UK

3. Liverpool Women's NHS Foundation Trust Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14485

Reference19 articles.

1. Bliss.The global picture.https://www.bliss.org.uk/research-campaigns/neonatal-care-statistics/the-global-picture. Accessed July 27 2020.

2. World Health Organisation.Safety of Medicines—A Guide to Detecting and Reporting Adverse Drug Reactions—Why Health Professionals Need to Take Action;2002.https://apps.who.int/iris/handle/10665/67378. Accessed July 27 2020.

3. Adverse Drug Reactions in Children—A Systematic Review

4. Adverse drug reactions in neonates: could we be documenting more?

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug related adverse event assessment in neonates in clinical trials and clinical care;Expert Review of Clinical Pharmacology;2024-08-13

2. The neonatal adverse event severity scale: current status, a stakeholders' assessment, and future perspectives;Frontiers in Pediatrics;2024-01-08

3. Performing clinical drug trials in acute and critically ill neonates and children;Essentials of Translational Pediatric Drug Development;2024

4. The needs, challenges, and opportunities from the academic researchers' perspective;Essentials of Translational Pediatric Drug Development;2024

5. Preface;Essentials of Translational Pediatric Drug Development;2024